Literature DB >> 21900424

Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles.

Larissa Spiegelberg1, Victoria Wahl-Jensen2, Larissa Kolesnikova1, Heinz Feldmann3, Stephan Becker1, Thomas Hoenen3,1.   

Abstract

The filoviral matrix protein VP40 orchestrates virus morphogenesis and budding. To do this it interacts with both the glycoprotein (GP1,2) and the ribonucleoprotein (RNP) complex components; however, these interactions are still not well understood. Here we show that for efficient VP40-driven formation of transcription and replication-competent virus-like particles (trVLPs), which contain both an RNP complex and GP1,2, the RNP components and VP40, but not GP1,2 and VP40, must be from the same genus. trVLP preparations contained both spherical and filamentous particles, but only the latter were able to infect target cells and to lead to genome replication and transcription. Interestingly, the genus specificity of the VP40-RNP interactions was specific to the formation of filamentous trVLPs, but not to spherical particles. These results not only further our understanding of VP40 interactions, but also suggest that special care is required when using trVLP or VLP systems to model virus morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21900424      PMCID: PMC3352568          DOI: 10.1099/vir.0.036863-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription.

Authors:  T Hoenen; N Biedenkopf; F Zielecki; S Jung; A Groseth; H Feldmann; S Becker
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

2.  Multivesicular bodies as a platform for formation of the Marburg virus envelope.

Authors:  Larissa Kolesnikova; Beate Berghöfer; Sandra Bamberg; Stephan Becker
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

3.  Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP.

Authors:  Shuzo Urata; Takeshi Noda; Yoshihiro Kawaoka; Shigeru Morikawa; Hideyoshi Yokosawa; Jiro Yasuda
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

4.  Vacuolar protein sorting pathway contributes to the release of Marburg virus.

Authors:  Larissa Kolesnikova; Thomas Strecker; Eiji Morita; Florian Zielecki; Eva Mittler; Colin Crump; Stephan Becker
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

5.  Establishment and application of an infectious virus-like particle system for Marburg virus.

Authors:  Jörg Wenigenrath; Larissa Kolesnikova; Thomas Hoenen; Eva Mittler; Stephan Becker
Journal:  J Gen Virol       Date:  2010-01-13       Impact factor: 3.891

6.  Differentiation of filoviruses by electron microscopy.

Authors:  T W Geisbert; P B Jahrling
Journal:  Virus Res       Date:  1995-12       Impact factor: 3.303

7.  Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.

Authors:  Thomas Hoenen; Allison Groseth; Larissa Kolesnikova; Steven Theriault; Hideki Ebihara; Bettina Hartlieb; Sandra Bamberg; Heinz Feldmann; Ute Ströher; Stephan Becker
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 8.  Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses.

Authors:  Thomas Hoenen; Allison Groseth; Fabian de Kok-Mercado; Jens H Kuhn; Victoria Wahl-Jensen
Journal:  Antiviral Res       Date:  2011-06-14       Impact factor: 5.970

9.  Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.

Authors:  Takeshi Noda; Hiroshi Sagara; Emiko Suzuki; Ayato Takada; Hiroshi Kida; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

10.  Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4.

Authors:  Joanna Timmins; Guy Schoehn; Sylvie Ricard-Blum; Sandra Scianimanico; Thierry Vernet; Rob W H Ruigrok; Winfried Weissenhorn
Journal:  J Mol Biol       Date:  2003-02-14       Impact factor: 5.469

View more
  8 in total

1.  The Integrity of the YxxL Motif of Ebola Virus VP24 Is Important for the Transport of Nucleocapsid-Like Structures and for the Regulation of Viral RNA Synthesis.

Authors:  Yuki Takamatsu; Larissa Kolesnikova; Martin Schauflinger; Takeshi Noda; Stephan Becker
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

2.  Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Authors:  Marc Schweneker; Andrea S Laimbacher; Gert Zimmer; Susanne Wagner; Elisabeth M Schraner; Michael Wolferstätter; Marieken Klingenberg; Ulrike Dirmeier; Robin Steigerwald; Henning Lauterbach; Hubertus Hochrein; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

3.  A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.

Authors:  Ari Watt; Felicien Moukambi; Logan Banadyga; Allison Groseth; Julie Callison; Astrid Herwig; Hideki Ebihara; Heinz Feldmann; Thomas Hoenen
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

4.  Modeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes.

Authors:  Thomas Hoenen; Ari Watt; Anita Mora; Heinz Feldmann
Journal:  J Vis Exp       Date:  2014-09-27       Impact factor: 1.355

5.  Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses.

Authors:  George G Daaboul; David S Freedman; Steven M Scherr; Erik Carter; Alexandru Rosca; David Bernstein; Chad E Mire; Krystle N Agans; Thomas Hoenen; Thomas W Geisbert; M Selim Ünlü; John H Connor
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

Review 6.  Forty-five years of Marburg virus research.

Authors:  Kristina Brauburger; Adam J Hume; Elke Mühlberger; Judith Olejnik
Journal:  Viruses       Date:  2012-10-01       Impact factor: 5.048

Review 7.  Marburg Virus Reverse Genetics Systems.

Authors:  Kristina Maria Schmidt; Elke Mühlberger
Journal:  Viruses       Date:  2016-06-22       Impact factor: 5.048

8.  Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.

Authors:  Punya Shrivastava-Ranjan; Mike Flint; Éric Bergeron; Anita K McElroy; Payel Chatterjee; César G Albariño; Stuart T Nichol; Christina F Spiropoulou
Journal:  MBio       Date:  2018-05-01       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.